1. Home
  2. NAII vs QNCX Comparison

NAII vs QNCX Comparison

Compare NAII & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natural Alternatives International Inc.

NAII

Natural Alternatives International Inc.

HOLD

Current Price

$2.30

Market Cap

15.8M

Sector

Health Care

ML Signal

HOLD

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$18.90

Market Cap

17.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAII
QNCX
Founded
1980
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.8M
17.1M
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
NAII
QNCX
Price
$2.30
$18.90
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
29.4K
168.7K
Earning Date
05-13-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.88
Revenue
$132,437,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$6.65
Revenue Growth
8.60
N/A
52 Week Low
$2.14
$0.08
52 Week High
$4.96
$19.26

Technical Indicators

Market Signals
Indicator
NAII
QNCX
Relative Strength Index (RSI) 39.55 86.85
Support Level N/A $0.89
Resistance Level $2.79 $19.26
Average True Range (ATR) 0.12 1.30
MACD -0.01 0.75
Stochastic Oscillator 43.06 95.16

Price Performance

Historical Comparison
NAII
QNCX

About NAII Natural Alternatives International Inc.

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products, to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segments. The company derives the majority of revenue from Private-Label Contract Manufacturing, which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.

Share on Social Networks: